TNFSF11 and cancer: Bone fusion factors released by bone metastatic cancer cells can induce increased synthesis of RANKL by adjacent osteoblasts, resulting in an increased risk of skeletal-related events (SRE) due to dysregulation of osteoblasts/osteoclasts and bone destruction (Buijs and van der Pluijm, 2009).